Clinical Trials Directory

Trials / Completed

CompletedNCT01697098

Dexamethasone for Preterm Labour

Dexamethasone Dosing Interval: 12 or 24 Hours Apart? A Randomized,Clinical Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Assiut University · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The investigators sought to determine whether the incidence of neonatal respiratory distress syndrome (RDS) in preterm fetuses is similar with 12- vs 24-hour dosing interval of dexamethasone.

Detailed description

The administration of glucocorticoids to accelerate fetal lung maturity in patients with preterm delivery plays an important role for obstetrics and neonatal care. Many studies have shown that maternal administration of glucocorticoids has a significant beneficial effect in decreasing the incidence of respiratory distress syndrome (RDS) in infants delivered at 28-34 weeks of gestation.

Conditions

Interventions

TypeNameDescription
DRUGDexamethasone 24 hours
DRUGDexamethasone 12

Timeline

Start date
2012-01-01
Primary completion
2012-07-01
Completion
2012-08-01
First posted
2012-10-02
Last updated
2012-10-02

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT01697098. Inclusion in this directory is not an endorsement.

Dexamethasone for Preterm Labour (NCT01697098) · Clinical Trials Directory